atorvastatin calcium

Product NDC: 68071-2994
11-digit product format: 680712994
Labeler code: 68071
Product ID: 68071-2994_2d53e488-a010-123b-e063-6294a90aa8ef
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: atorvastatin calcium, film coated
Dosage form: TABLET
Route: ORAL
Labeler: NuCare Pharmaceuticals,Inc.
Application: ANDA209912
Marketing category: ANDA
Marketing start: 2018-06-18
Substance: ATORVASTATIN CALCIUM TRIHYDRATE
Active strength: 40 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68071-2994-9	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68071-2994-9	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68071-2994-9	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A209912-001	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18
A209912-002	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18
A209912-003	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18
A209912-004	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A209912-001	AB
A209912-002	AB
A209912-003	AB
A209912-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209912-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-06-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209912-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-06-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209912-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-06-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209912-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-06-18	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A209912-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A209912-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A209912-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A209912-004	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A209912-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209912-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209912-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209912-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A209912-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209912-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209912-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209912-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209912-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209912-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209912-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209912-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209912-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209912-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209912-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209912-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209912-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209912-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209912-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209912-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209912-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209912-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209912-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209912-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209912-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209912-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209912-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209912-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209912-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209912-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209912-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209912-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209912-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209912-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209912-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209912-004	AB	1	`5bbf6a4d5a75…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: atorvastatin calcium
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ATORVASTATIN CALCIUM TRIHYDRATE	40 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
48A5M73Z4Q	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
617311	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
faba7fc1-2e08-74ef-e053-6394a90afd04	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fa898d56-9495-d6f0-309b-68a5d8e3914a	Product name	4	20260305
d25cba4b-d79e-4890-8837-1382f7d09489	Product name	1	20231002
91774e91-b249-45e3-8ff8-4b5db2927a69	Product name	1	20230718
03fb3cda-d60a-4873-94e9-6fa77cfb1a1c	Product name	1	20220302
34152997-af0b-acf4-dcaf-37211afe8ca4	Product name	9	20210312
46fdf265-6d5a-1bfb-93db-d82a4ea8aa81	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68071-2994-9	2025-02-04	C162847	48780-1	2cef2736-69fd-d83d-e063-dadaa90ab31f	These highlights do not include all the information needed to use ATORVASTATIN CALCIUM TABLETS safely and effectively. See full prescribing information for ATORVASTATIN CALCIUM TABLETS. ATORVASTATIN CALCIUM tablets, for oral use Initial U.S. Approval: 1996
68071-2994-9	2025-01-30	C162847	48780-1	2cef2736-69fd-d83d-e063-dadaa90ab31f	These highlights do not include all the information needed to use ATORVASTATIN CALCIUM TABLETS safely and effectively. See full prescribing information for ATORVASTATIN CALCIUM TABLETS. ATORVASTATIN CALCIUM tablets, for oral use Initial U.S. Approval: 1996

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68071-2994-9	atorvastatin calcium	90 in 1 BOTTLE	TABLET	90		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68071-2994	ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM, FILM COATED) TABLET [NUCARE PHARMACEUTICALS,INC.]	2	Current NDC, 1 package rows	20250206_faba7fc1-2e08-74ef-e053-6394a90afd04.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	Preferred Pharmaceuticals Inc.	a92f2742-1763-4a02-94b7-e8db714eb2f4	2026-03-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	NuCare Pharmaceuticals, Inc.	4344f574-9b86-7ae5-e063-6294a90a79e8	2025-11-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	Preferred Pharmaceuticals Inc.	7fc58ce3-f069-409b-b36f-bb23ce21fb6f	2025-09-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	NuCare Pharmaceuticals, Inc.	3ef3b6e3-83dc-e06a-e063-6394a90a152c	2025-09-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	Rising Pharma Holdings, Inc.	73cefb0b-1747-4fe0-b252-377f4ed94c6f	2025-08-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	NuCare Pharmaceuticals, Inc.	3bde7950-3d25-a86e-e063-6394a90ae623	2025-08-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	Bryant Ranch Prepack	9c58c4cd-fe1c-4db7-832c-874766e4da21	2025-06-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	NuCare Pharmaceuticals,Inc.	3778125d-b3d9-2853-e063-6394a90aa863	2025-06-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	Bryant Ranch Prepack	b8fa04f5-0d56-49ca-bb01-f0dd3b472164	2025-05-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	Bryant Ranch Prepack	17f779f2-48ac-4719-bf37-0ee162f91144	2025-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	Preferred Pharmaceuticals Inc.	bb825db4-3798-4d69-8559-46b3ab0c8bd9	2025-03-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
atorvastatin calcium	ATORVASTATIN CALCIUM, FILM COATED	NuCare Pharmaceuticals,Inc.	faba7fc1-2e08-74ef-e053-6394a90afd04	2025-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912 ndc (product): 68071-2994
atorvastatin calcium	ATORVASTATIN CALCIUM, FILM COATED	NuCare Pharmaceuticals,Inc.	0a9d4e36-305a-2120-e063-6294a90a01bd	2025-02-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912
Atorvastatin Calcium	ATORVASTATIN CALCIUM, FILM COATED	Bryant Ranch Prepack	32b40825-6b0b-4025-86f5-b4e453efea92	2024-06-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209912 application number: ANDA209912

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
48A5M73Z4Q	ATORVASTATIN CALCIUM TRIHYDRATE	344423-98-9	ATORVASTATIN CALCIUM TRIHYDRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
617311	atorvastatin calcium 40 MG Oral Tablet	PSN	faba7fc1-2e08-74ef-e053-6394a90afd04	2
617311	atorvastatin 40 MG Oral Tablet	SCD	faba7fc1-2e08-74ef-e053-6394a90afd04	2
617311	atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet	SY	faba7fc1-2e08-74ef-e053-6394a90afd04	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
68071-2994-9	68071299409	90 TABLET in 1 BOTTLE (68071-2994-9)	90 tablet	2023-05-02	No	No	Current